Imacis-1

Known as: Imacis 1 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1988-1993
012319881993

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
We evaluated the intravenous infusion of a cocktail of I-131 anti-CEA and anti-CA19-9 monoclonal antibody F(ab')2 (IMACIS-1) in… (More)
Is this relevant?
1993
1993
IMACIS-1 is a radiopharmaceutical containing a mixture of Iodine-131 labeled monoclonal antibodies to CEA and CA19-9. IMACIS-1… (More)
Is this relevant?
1990
1990
The clinical trials of immunoscintigraphy with a cocktail of 131I anti CEA monoclonal antibody F(ab')2 and 131I anti CA 19-9… (More)
Is this relevant?
1990
1990
The sensitivity of immunoscintigraphy (ISC) with monoclonal antibodies (Mab) depends on the Mab type, the radiophysical… (More)
Is this relevant?
1990
1990
A study was made on 2 types of 131I-labeled anti-CA 19-9 and anti-CEA mouse monoclonal antibodies (IMACIS-1) against human cancer… (More)
Is this relevant?
1989
1989
The clinical usefulness of a I-131 anti CEA F(ab')2 MoAB and CA 19-9 F(ab')2 MoAB cocktail(IMACIS-1) for the localization of a… (More)
Is this relevant?
1989
1989
To determine if IMACIS-1 might have the capability of specifically pinpointing an adenocarcinoma in the human lung, xenografts of… (More)
Is this relevant?
1988
1988
Imacis-1 is a combination of F (ab')2 antibody fragments, of two monoclonal antibodies, anti-CEA and 19.9, radiolabelled with… (More)
Is this relevant?